Erlotinib extends survival of patients with relapsed non-small-cell lung cancer

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY-NEW YORK | 2004年 / 18卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1077 / 1077
页数：1
相关论文
共 50 条
  • [41] Erlotinib in the first-line treatment of non-small-cell lung cancer
    D'Arcangelo, Manolo
    Cappuzzo, Federico
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (05) : 523 - 533
  • [42] A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study†
    Aerts, J. G.
    Codrington, H.
    Lankheet, N. A. G.
    Burgers, S.
    Biesma, B.
    Dingemans, A. -M. C.
    Vincent, A. D.
    Dalesio, O.
    Groen, H. J. M.
    Smit, E. F.
    ANNALS OF ONCOLOGY, 2013, 24 (11) : 2860 - 2865
  • [43] Surrogate end points for survival in the target treatment of advanced non-small-cell lung cancer with gefitinib or erlotinib
    Li, Xiaoqin
    Liu, Shan
    Gu, Hangang
    Wang, Deqiang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (11) : 1963 - 1969
  • [44] Surrogate end points for survival in the target treatment of advanced non-small-cell lung cancer with gefitinib or erlotinib
    Xiaoqin Li
    Shan Liu
    Hangang Gu
    Deqiang Wang
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 1963 - 1969
  • [45] Erlotinib therapy in non small cell lung cancer patients-survival of "poor prognosis patients"
    Pesck, Milos
    Krejci, Jana
    Skrickova, Jana
    Zatloukal, Petr
    Kolek, Vitezslav
    Salajka, Frantisek
    Koubkova, Leona
    Sixtova, Dimka
    Petruzelka, Lubos
    Roubec, Jaromir
    Vyzula, Rostislav
    Pavlik, Tomas
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S704 - S704
  • [46] Effect of genetic polymorphisms on erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancer
    Endo-Tsukude, Chihiro
    Sasaki, Ji-ichiro
    Saeki, Sho
    Iwamoto, Norihiro
    Inaba, Megumi
    Ushijima, Sunao
    Kishi, Hiroto
    Fujii, Shinji
    Semba, Hiroshi
    Kashiwabara, Kosuke
    Tsubata, Yukari
    Kai, Yuki
    Saito, Hideyuki
    Isobe, Takeshi
    Kohrogi, Hirotsugu
    Hamada, Akinobu
    CANCER RESEARCH, 2015, 75
  • [47] Radiation Pneumonitis in Patients with Non-Small-Cell Lung Cancer Treated with Erlotinib Concurrent with Thoracic Radiotherapy
    Zhuang, Hongqing
    Yuan, Zhiyong
    Chang, Joe Y.
    Wang, Jun
    Pang, Qingsong
    Zhao, Lujun
    Wang, Ping
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (06) : 882 - 885
  • [48] The concentration of erlotinib in the cerebrospinal fluid of patients with brain metastasis from non-small-cell lung cancer
    Deng, Yanming
    Feng, Weineng
    Wu, Jing
    Chen, Zecheng
    Tang, Yicong
    Zhang, Hua
    Liang, Jianmiao
    Xian, Haibing
    Zhang, Shunda
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (01) : 116 - 120
  • [49] Is erlotinib really active after failure of gefitinib in advanced non-small-cell lung cancer patients?
    Vasile, E.
    Tibaldi, C.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2009, 20 (04) : 790 - 791
  • [50] Gefitinib or erlotinib in previously treated non-small-cell lung cancer patients: a cohort study in Taiwan
    Chang, Chia-Hao
    Lee, Chih-Hsin
    Ko, Jen-Chung
    Chang, Lih-Yu
    Lee, Ming-Chia
    Wang, Jann-Yuan
    Yu, Chong-Jen
    CANCER MEDICINE, 2017, 6 (07): : 1563 - 1572
12345